Promisingly, obesity rates have also started to decline since 2022, with experts suspicious that GLP-1 drugs have contributed to the trend
Pure Encapsulations Liposomal Glutathione features glutathione in a liposomal delivery system: BioGlute proprietary blend of glutathione and phosphatidylcholine with natural liposome formation due to the hydrophobic and hydrophilic nature of phospholipids
Phase 2 trial results (48 weeks, adults with obesity): 1 mg dose: 7.2% body weight loss 4 mg dose: 12.9% body weight loss 8 mg dose: 17.3% body weight loss 12 mg dose: 24.2% body weight loss Placebo: 1.6% body weight loss Phase 3 TRIUMPH-4 results: 9 mg dose: 20.0% body weight loss (22.9 kg / 50.5 lbs) 12 mg dose: 23.7% body weight loss (27.2 kg / 60.0 lbs) Placebo: 4.6% body weight loss In a separate phase 3 analysis, retatrutide at the highest dose achieved up to 28.7% weight loss
Keeps your system resilient and ready for anything
Preclinical Benefits in Rodent and In Vitro Research Most mechanistic and efficacy data for GHK-Cu come from in vitro systems and animal experiments, including numerous rat studies examining skin repair, organ protection, and systemic inflammation
